Objectives: describe the epidemiological, clinical and anatomopathological aspects of this tumor in central Tunisia. Method: This was a retrospective descriptive study of histologically diagnosed cases of pheochromocytoma from january 1993 to december 2023, collected in the cancer registry of central Tunisia. Results: We collected 47 cases of pheochromocytoma with an average of 1.52 cases/year. The mean age was 48.06 years. The sex ratio was 0.68. It was most often discovered in the presence of a tumor syndrome (57.50%) with arterial hypertension (37.50%) and Menard’s triad (27.50%). Only total adrenalectomy specimens were referred, 6.38% of which were extended to the kidney. The left adrenal gland was most affected in 56.52% of cases. On gross examination, the tumor had a mean size of 6.92 cm. It was usually well limited (91.67%), encapsulated (84.85%), greyish (53.85%), friable (50%), with hemorrhagic (65.97%). Histologically, 65.96% of cases were potentially non-aggressive, 34.04% aggressive and 4.25% metastatic. It was composite in 4.25% with a ganglioneuroma component. Stage II was most common in 63.6%. Immunohistochemical confirmation was performed in 59.57%. Conclusion: Pheochromocytoma is rare in central Tunisia. It mainly affects adult women. It is usually non-aggressive and diagnosed at a localized stage. Studies of the genetic are recommended.
References
[1]
Tevosian, S.G. and Ghayee, H.K. (2019) Pheochromocytomas and Paragangliomas. Endocrinology and Metabolism Clinics of North America, 48, 727-750. https://doi.org/10.1016/j.ecl.2019.08.006
[2]
Berends, A.M.A., Buitenwerf, E., de Krijger, R.R., Veeger, N.J.G.M., van der Horst-Schrivers, A.N.A., Links, T.P., et al. (2018) Incidence of Pheochromocytoma and Sympathetic Paraganglioma in the Netherlands: A Nationwide Study and Systematic Review. European Journal of Internal Medicine, 51, 68-73. https://doi.org/10.1016/j.ejim.2018.01.015
[3]
Eymerit-Morin, C., Camilo, A. and Petit, T. (2017) Endocrine System. In: Adem, C. and Petit, T., Eds., Mémento de pathologie, Vernazobres-Grego, 682.
[4]
Sagna, Y., Yanogo, D.A.R., Guira, O., Bagbila, A.P., Tiéno, H. and Drabo, J.Y. (2014) Phéochromocytome à Ouagadougou (Burkina Faso): À propos de trois cas. Annales d’Endocrinologie, 75, 473. https://doi.org/10.1016/j.ando.2014.07.687
[5]
Zantour, B., Tahri, S., Boubaker, F., Elati, Z., Charrada, I., Mrabet, H., et al. (2018) Le phéochromocytome: Étude 10 cas. Annales d’Endocrinologie, 79, 397. https://doi.org/10.1016/j.ando.2018.06.653
[6]
Zaher, F.Z., Okoumou Moko, A., Doubi, S., Elmghari, G. and Elansari, N. (2017) Le phéochromocytome, que peuvent être les modalités de révélation? Annales d’Endocrinologie, 78, 364. https://doi.org/10.1016/j.ando.2017.07.481
[7]
Takongmo, S., Wawo Yonta, E., Gonsu Kamga, H., Ngongang, J., Moyo, S.J., Essame, O., et al. (2010) Diagnosis of Pheochromocytoma in Yaoundé (Cameroon): Study of Nine Cases. MédecineTropicale Revue, 70, 274-276.
[8]
Tekaya, A., Kefi, A., Khefifi, S., Oueslati, O., Ben Abdelghni, K., Turki, S., et al. (2021) Particularités du Phéochromocytome en médecine interne. Annales d’Endocrinologie, 82, 436. https://doi.org/10.1016/j.ando.2021.08.529
[9]
Mekni, S., Ben Nacef, I., Jenouiz, Z., Rojbi, I., Mchirgui, N., Lakhoua, Y., et al. (2017) Les complications métaboliques du phéochromocytome: À propos de 30 cas. Annales d’Endocrinologie, 78, 363-364. https://doi.org/10.1016/j.ando.2017.07.480
[10]
Koama, A., Tiemtore Kambou, A.M.B., N’de Ouedraogo, N.A., Ouedraogo, P.A., Yameogo, L.C., Nitiema, C.K., et al. (2019) Pheochromocytoma and Paraganglioma: Role of the Multi-Bar Scanner (Burkina Faso). Science and Technology, Health Sciences, 42, 43-48.
[11]
Bettaiebi, A., Jemel, M., Ktari, K., Missaoui, S., Sayadi, H., Graja, S., et al. (2015) Les aspects cliniques et épidémiologiques des phéochromocytomes à travers une série de 23 cas. Annales d’Endocrinologie, 76, 465-466. https://doi.org/10.1016/j.ando.2015.07.552
[12]
Rabii, R., Salomon, L., Saint, F., Hoznek, A., Cicco, A., Chopin, D., et al. (2001) Treatment of Pheochromocytomas by Retroperitoneal Laparoscopy. Journal of Progress in Urology, 11, 16-21.
[13]
Nel, D., Panieri, E., Malherbe, F., Steyn, R. and Cairncross, L. (2020) Surgery for Pheochromocytoma: A Single‐center Review of 60 Cases from South Africa. World Journal of Surgery, 44, 1918-1924. https://doi.org/10.1007/s00268-020-05420-6
[14]
World Health Organization (2022) Classification of Tumors of Endocrine Organs. 5th Edition, IARC.
[15]
Proye, C., Verin, P., Sautier, M. and Thevenin, D. (1989) Pheochromocytoma, Experience of 60 Operations. Journal of Urology, 95, 289-295.
[16]
Baguet, J., Hammer, L., Mazzuco, T., Chabre, O., Mallion, J., Sturm, N., et al. (2004) Circumstances of Discovery of Phaeochromocytoma: A Retrospective Study of 41 Consecutive Patients. European Journal of Endocrinology, 150, 681-686. https://doi.org/10.1530/eje.0.1500681
[17]
Jandou, I., Moataz, A., Dakir, M., Debbagh, A. and Aboutaieb, R. (2021) Malignant Pheochromocytoma: A Diagnostic and Therapeutic Dilemma. International Journal of Surgery Case Reports, 83, Article ID: 106009. https://doi.org/10.1016/j.ijscr.2021.106009
[18]
Kopetschke, R., Slisko, M., Kilisli, A., Tuschy, U., Wallaschofski, H., Fassnacht, M., et al. (2009) Frequent Incidental Discovery of Phaeochromocytoma: Data from a German Cohort of 201 Phaeochromocytoma. European Journal of Endocrinology, 161, 355-361. https://doi.org/10.1530/eje-09-0384
[19]
Sidibé, E.H. (2001) Pheochromocytoma in Africa: Rarity, Severity and Ectopia. Annals of Urology, 35, 17-21.
[20]
N’Guessan, H.A., Keli, E., Casanelli, J.M., Yapo, P., Yakpa, P., Kadio, R.M., et al. (1990) Pheochro-Mocytoma in Black Africa: About 9 Cases. Surgery Memoir of the Academy of Surgery, 116, 315-319.
[21]
Chandurkar, V. and Holland, J. (2014) A Retrospective Study of Surgically Excised Phaeochromocytomas in Newfoundland, Canada. Indian Journal of Endocrinology and Metabolism, 18, 542-545. https://doi.org/10.4103/2230-8210.137514
[22]
Kulis, T., Knezevic, N., Pekez, M., Kastelan, D., Grkovic, M. and Kastelan, Z. (2012) Laparoscopic Adrenalectomy: Lessons Learned from 306 Cases. Journal of Laparoendoscopic & Advanced Surgical Techniques, 22, 22-26. https://doi.org/10.1089/lap.2011.0376
[23]
Djeffal, C., Fourmarier, M., Bracq, A., Saint, F. and Petit, J. (2008) La taille tumorale: Critère prédictif des variations hémodynamiques peropératoires dans la chirurgie du phéochromocytome surrénalien. ProgrèsenUrologie, 18, 507-511. https://doi.org/10.1016/j.purol.2008.03.033
[24]
Zongo, N., Koama, A., Kambou/Tiemtoré, B.M.A., Nde/Ouédraogo, N.A., Zida, M., Ouédraogo, M.N.L., et al. (2019) Ectopic Pheochromocytoma or Paraganglioma of the Zuckerkandl Organ. International Journal of Surgery Case Reports, 60, 120-122. https://doi.org/10.1016/j.ijscr.2019.06.007
[25]
Duan, K. and Mete, O. (2016) Algorithmic Approach to Neuroendocrine Tumors in Targeted Biopsies: Practical Applications of Immunohistochemical Markers. Cancer Cytopathology, 124, 871-884. https://doi.org/10.1002/cncy.21765
[26]
Santi, R., Rapizzi, E., Canu, L., Ercolino, T., Baroni, G., Fucci, R., et al. (2017) Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHX Gene Mutation. Anticancer Research, 37, 805-812. https://doi.org/10.21873/anticanres.11381
[27]
Thompson, L.D.R. (2002) Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign from Malignant Neoplasms. The American Journal of Surgical Pathology, 26, 551-566. https://doi.org/10.1097/00000478-200205000-00002
[28]
Kimura, N., Takayanagi, R., Takizawa, N., Itagaki, E., Katabami, T., Kakoi, N., et al. (2014) Pathological Grading for Predicting Metastasis in Phaeochromocytoma and Paraganglioma. Endocrine-Related Cancer, 21, 405-414. https://doi.org/10.1530/erc-13-0494
